TRACKING BIOETHICS: TRANSPARENCY, TRUST AND THE INDUSTRY’S SOCIAL IMPERATIVES

With all eyes on healthcare innovation in these unparalleled times, along with the renewed discussion around global access to therapeutics and vaccines, never has the life science industry been so scrutinized and in the public eye. The obligations of responsible and transparent research, clinical trials and corporate practices have never been so important for the planet’s concerned citizenry, as the ethical components of healthcare have taken center stage. This panel, led by the creative team behind Good Medicine, a new collaboration between Scientific American and Bioethics International, will explore the most pressing issues in this arena and draw on the findings from The Good Pharma Scorecard, an industry tracking initiative that is growing in scope, reach and relevancy.